BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

489 related articles for article (PubMed ID: 19390314)

  • 41. [Cardiac pathology in patients after therapy for Hodgkin's lymphoma].
    Danilenko AA; Shakhtarina SV
    Vopr Onkol; 2011; 57(1):119-25. PubMed ID: 21598720
    [No Abstract]   [Full Text] [Related]  

  • 42. Late effects of treatment in children with cancer.
    Neglia JP
    Semin Pediatr Surg; 1993 Feb; 2(1):29-36. PubMed ID: 8062020
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Second primary cancers: an overview.
    Ng AK; Travis LB
    Hematol Oncol Clin North Am; 2008 Apr; 22(2):271-89, vii. PubMed ID: 18395150
    [TBL] [Abstract][Full Text] [Related]  

  • 44. ACR Appropriateness Criteria on Hodgkin's lymphoma: favorable prognosis stage I and II.
    Das P; Ng A; Constine LS; Hodgson DC; Mendenhall NP; Morris DE; Yunes MJ; Chauvenet AR; Hudson MM; Winter JN
    J Am Coll Radiol; 2008 Oct; 5(10):1054-66. PubMed ID: 18812149
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Understanding the risk of second malignant tumors in children with Hodgkin's disease.
    Donaldson SS; O'Brien MM
    Int J Radiat Oncol Biol Phys; 2008 Sep; 72(1):4-5. PubMed ID: 18722256
    [No Abstract]   [Full Text] [Related]  

  • 46. Salvage therapy for Hodgkin's lymphoma.
    Quddus F; Armitage JO
    Cancer J; 2009; 15(2):161-3. PubMed ID: 19390313
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Targeting cellular FLICE-like inhibitory protein as a novel approach to the treatment of Hodgkin's lymphoma.
    Dutton A; Burns AT; Young LS; Murray PG
    Expert Rev Anticancer Ther; 2006 Jun; 6(6):911-9. PubMed ID: 16761935
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Cardiopulmonary response to exercise in patients with different degrees of lung toxicity after radio-chemotherapy for Hodgkin's disease.
    Villani F; Busia A; Villani M; Laffranchi A; Viviani S; Bonfante V
    Anticancer Res; 2009 Feb; 29(2):777-83. PubMed ID: 19331235
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Roles of radiation dose and chemotherapy in the etiology of stomach cancer as a second malignancy.
    van den Belt-Dusebout AW; Aleman BM; Besseling G; de Bruin ML; Hauptmann M; van 't Veer MB; de Wit R; Ribot JG; Noordijk EM; Kerst JM; Gietema JA; van Leeuwen FE
    Int J Radiat Oncol Biol Phys; 2009 Dec; 75(5):1420-9. PubMed ID: 19931732
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Gonadal dysfunction and fertility problems in cancer survivors.
    Brydøy M; Fosså SD; Dahl O; Bjøro T
    Acta Oncol; 2007; 46(4):480-9. PubMed ID: 17497315
    [TBL] [Abstract][Full Text] [Related]  

  • 51. German Hodgkin's Lymphoma Study Group trials: lessons from the past and current strategies.
    Draube A; Behringer K; Diehl V
    Clin Lymphoma Myeloma; 2006 May; 6(6):458-68. PubMed ID: 16796776
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Osteosarcoma of the mandible--second cancer in a case of Hodgkin's lymphoma post-chemotherapy.
    De S; Ghosh S; Mondal D; Sur PK
    J Cancer Res Ther; 2010; 6(3):336-8. PubMed ID: 21119269
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The natural history of thyroid function abnormalities after treatment for childhood cancer.
    Madanat LM; Lähteenmäki PM; Alin J; Salmi TT
    Eur J Cancer; 2007 May; 43(7):1161-70. PubMed ID: 17391953
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Thyroid nodules and survivors of Hodgkin's disease.
    Oeffinger KC; Sklar CA; Hudson MM
    Am Fam Physician; 2003 Sep; 68(6):1016, 1018-9; discussion 1019. PubMed ID: 14524392
    [No Abstract]   [Full Text] [Related]  

  • 55. The oral implications of Hodgkin's disease.
    Herrin HK
    Gen Dent; 1999; 47(6):572-5. PubMed ID: 10687450
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Late complications of curative treatment in Hodgkin's disease.
    Bookman MA; Longo DL; Young RC
    JAMA; 1988 Aug; 260(5):680-3. PubMed ID: 3392794
    [No Abstract]   [Full Text] [Related]  

  • 57. Monitoring for cardiovascular disease in survivors of childhood cancer: report from the Cardiovascular Disease Task Force of the Children's Oncology Group.
    Shankar SM; Marina N; Hudson MM; Hodgson DC; Adams MJ; Landier W; Bhatia S; Meeske K; Chen MH; Kinahan KE; Steinberger J; Rosenthal D;
    Pediatrics; 2008 Feb; 121(2):e387-96. PubMed ID: 18187811
    [TBL] [Abstract][Full Text] [Related]  

  • 58. What is the price of survival in Hodgkin's lymphoma? Long-term follow-up of cured patients.
    Zsófia M; Katalin K; Judit V; György S; Arpád I
    Hematol Oncol; 2007 Dec; 25(4):178-83. PubMed ID: 17607807
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Reassurance following breast screening recall for female survivors of Hodgkin's lymphoma.
    Absolom K; Greenfield D; Ross R; Davies H; Hancock B; Eiser C
    Breast; 2007 Dec; 16(6):590-6. PubMed ID: 17582768
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Late effects of therapy for Hodgkin's lymphoma.
    Adams MJ; Constine LS; Lipshultz SE
    Curr Hematol Malig Rep; 2007 Jul; 2(3):143-50. PubMed ID: 20425363
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 25.